Skip to content

A Longitudinal Study of Multimodal Resonance Imaging in Stroke Patients

A Longitudinal Study of Multimodal Resonance Imaging in Stroke Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02024503
Enrollment
800
Registered
2013-12-31
Start date
2013-09-30
Completion date
2015-12-31
Last updated
2013-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke, fMRI, DTI

Brief summary

Imaging of the ischaemic penumbra with a particular diffusion-weighted imaging (DWI)/ perfusion-weighted imaging (PWI) mismatch is a promising approach to the selection of patients with acute ischaemic stroke for trials of intervention. The investigators want to apply multimodal resonance imaging methods such as functional magnetic resonance imaging ( fMRI), diffusion tensor imaging (DTI), arterial spin labeling (ASL) to guide treatment and predict the prognosis of stroke.

Interventions

None listed

Sponsors

Zhongda Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

Time from the onset of stroke till hospital within 24 hours. With clinical characteristics such as hemiplegia, headache. Willing and able to comply with the study procedures and provide written informed consent to participate in the study. Patients must understand the nature of the study and give informed consent.

Exclusion criteria

The onset of stroke out of 24 hours. Pregnant women. Patients with intracranial metallic bodies from prior neurosurgical procedure, implanted pacemaker, medication pump, vagal stimulator, deep brain stimulator, TENS unit or ventriculoperitoneal shunt. Past history of seizures within one year or unexplained loss of consciousness. Family history of epilepsy.

Design outcomes

Primary

MeasureTime frame
Functional recoveryParticipants will be followed till die or lost to follow-up,an expected average of three year.

Secondary

MeasureTime frameDescription
Over survivalParticipants will be followed till die or lost to follow-up,an expected average of three yearTime from stenting to the day when the patients died or lost to the follow-up

Countries

China

Contacts

Primary ContactCheng-yu Peng
514974848@qq.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026